Mechanical, physical and biological characterization of soy protein films loaded with bupivacaine for wound healing applications

Filament-woven SF/PA gel for removing ultrafine nanoparticles and unmanageable hazardous pollutants by "all-in-one net"

The current state of the world's water resources is facing serious challenges, and the current water purification processes are designed for a single, more specific contaminant, with more stringent constraints, which are not suitable for emergency water treatment in stochastic environment and may cause secondary pollution. It is necessary to provide a water purification method that is convenient, easy-to-operate, one-step treatment of multiple pollutants. Herein, silk fibroin (SF) that extracted from discarded silkworm cocoons and recycled silk and phytic acid (PA) are "woven" into a network structure through hydrogen bonding and electrostatic interaction to form a unique gel, which could be used to remove different pollutants by "sweeping and catching" and physical adsorption. SF/PA gels have been demonstrated to adsorb more than 99.9% of ultrafine nanoparticles in water, and many unmanageable hazardous pollutants can also be removed by "All-in-one Net", including bacteria, polystyrene microsphere, insoluble antibiotics and pesticides. In addition, SF/PA gel from waste resources can not only achieve the purpose of treating waste with waste, but also the products after removal of pollutants can be reused as biochar-based fertilizer to improve the soil environment. This process established a sustainable closed-loop system without secondary pollution, providing an excellent scheme for the sustainable use of resources.

Soy Protein-Based Wound Dressings: A Review of Their Preparation, Properties, and Perspectives

Wound healing is a major challenge worldwide, and people have been researching wound dressings that can promote wound healing for decades. Natural biobased materials, such as polysaccharides and proteins, have been widely used in the development of wound dressings. Among them, soy protein-based materials have attracted the interest of a wide range of researchers due to their safety, biocompatibility, controlled degradation, and ability to be mixed with other materials. However, there has been a lack of comments on these soy protein-based wound dressings. This work reviews various forms of soy protein-based wound dressings, such as hydrogels, films, and others, which could be prepared through physical/chemical cross-linking with synthetic or natural polymers. The important role played by soy protein-based materials in the wound healing phase and their properties will be examined, such as their anti-inflammatory, antioxidant, angiogenesis-promoting, cellular biocompatibility, self-healing ability, adhesion, antimicrobial, and tunable mechanical properties. Additionally, insights into the market prospects and trends for soy protein dressings are provided, clarifying the enormous development potential of soy protein as a new type of wound repair material.

In vivo study of the efficacy of bupivacaine-eluting novel soy protein wound dressings in a rat burn model

Dealing with wound related pain is an integral part of treatment. Systemic administration of analgesic and anesthetic agents is a common solution for providing pain relief to patients but comes at a risk of severe side effects as well as addiction. To overcome these issues, research efforts were madeto provide a platform for local controlled release of pain killers. We have developed a bilayer soy protein-based wound dressing for the controlled local release of bupivacaine to the wound site. The combination of a dense and a porous layer provides a platform for cell growth and proliferation as well as physical protection to the wound site. The current study focuses on the in vitro bupivacaine release profile from the dressing and the corresponding in vivo results of pain levels in a second-degree burn model on rats. The Rat Grimace Scale method and the Von Frey filaments method were used to quantify both, spontaneous pain and mechanically induced pain. A high burst release of 61.8 ± 1.9% of the loaded drug was obtained during the initial hour, followed by a slower release rate during the following day. The animal trials show that the RGS scores of the bupivacaine-treated group were significantly lower than these of the untreated group, proving a decrease of 51-68% in pain levels during days 1-3 after burn. Hence, successful pain reduction of spontaneous pain as well as mechanically induced pain, for at least three days after burn was achieved. It is concluded that our novel bupivacaine eluting soy protein wound dressings are a promising new concept in the field of local controlled drug release for pain management.

A Recent Update on Drug Delivery Systems for Pain Management

Pain remains a global health challenge affecting approximately 1.5 billion people worldwide. Pain has been an implicit variable in the equation of human life for many centuries considering different types and the magnitude of pain. Therefore, developing an efficacious drug delivery system for pain management remains an open challenge for researchers in the field of medicine. Lack of therapeutic efficacy still persists, despite high throughput studies in the field of pain management. Research scientists have been exploiting different alternatives to curb the adverse side effects of pain medications or attempting a more substantial approach to minimize the prevalence of pain. Various drug delivery systems have been developed such as nanoparticles, microparticles to curb adverse side effects of pain medications or minimize the prevalence of pain. This literature review firstly provides a brief introduction of pain as a sensation and its pharmacological interventions. Second, it highlights the most recent studies in the pharmaceutical field for pain management and serves as a strong base for future developments. Herein, we have classified drug delivery systems based on their sizes such as nano, micro, and macro systems, and for each of the reviewed systems, design, formulation strategies, and drug release performance has been discussed.